Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline With Cancer-Focused Counseling for Patients With Cancer: A Pilot Randomized Comparative Effectiveness Trial

Jesse T. Kaye, Thomas M. Piasecki, Michael C. Fiore, Timothy B. Baker, Mark E. Zehner, Brian S. Williams, Wendy S. Slutske, Danielle E. McCarthy

Open source

DOI
10.1200/oa-25-00169
Published
2026-01
Container
JCO Oncology Advances
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/oa-25-00169,
  title = {Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline With Cancer-Focused Counseling for Patients With Cancer: A Pilot Randomized Comparative Effectiveness Trial},
  author = {Jesse T. Kaye and Thomas M. Piasecki and Michael C. Fiore and Timothy B. Baker and Mark E. Zehner and Brian S. Williams and Wendy S. Slutske and Danielle E. McCarthy},
  year = {2026},
  journal = {JCO Oncology Advances},
  doi = {10.1200/oa-25-00169},
  url = {https://doi.org/10.1200/oa-25-00169}
}

RIS

TY  - JOUR
TI  - Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline With Cancer-Focused Counseling for Patients With Cancer: A Pilot Randomized Comparative Effectiveness Trial
AU  - Jesse T. Kaye
AU  - Thomas M. Piasecki
AU  - Michael C. Fiore
AU  - Timothy B. Baker
AU  - Mark E. Zehner
AU  - Brian S. Williams
AU  - Wendy S. Slutske
AU  - Danielle E. McCarthy
PY  - 2026
JO  - JCO Oncology Advances
DO  - 10.1200/oa-25-00169
UR  - https://doi.org/10.1200/oa-25-00169
ER  - 

APA

Kaye, J. T., Piasecki, T. M., Fiore, M. C., Baker, T. B., Zehner, M. E., Williams, B. S., Slutske, W. S., & McCarthy, D. E. (2026). Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline With Cancer-Focused Counseling for Patients With Cancer: A Pilot Randomized Comparative Effectiveness Trial. JCO Oncology Advances. https://doi.org/10.1200/oa-25-00169

Source records